Combining the results of different binary diagnostic markers to reach maximum area under the receiver operating characteristic (ROC) curve is the aim of the present study. To this end, the Neyman-Pearson lemma is utilized to combine the results of several binary diagnostic markers to obtain an optimum decision rule. The applied procedure has two advantages: (1) no distributional assumptions are considered for diagnostic markers, and (2) the derived rules are optimal in the sense that their ROC curves are maximized at each point. As an application, eleven different subsets of six diagnostic markers of classical Hodgkin lymphoma (CD15, CD20, CD30, CD3, Pax-5 and LCA) are applied. Four best subsets are then selected based on the area under the ROC curve (AUC) and their optimal decision rules are derived at 0.05 error rate.
Introduction
Generally, diagnostic (or screening) tests in medicine classify individuals into two diseased or non-diseased groups, inherently or by defining a cut point. Evaluating the performance of these tests is of increasing importance in practice. The receiver operating characteristic (ROC) curve is a very popular tool for evaluating a single screening or diagnostic test. The ROC curve plots true positive rate (TPR), which is also called sensitivity, against its false positive rate (FPR), which is one minus the specificity. The ROC curve represents the ability of a test to make the distinction between diseased and non-diseased individuals being examined over all decision thresholds. In the ROC curve space, the points ( ) 0 , 0 and ( ) 1 , 1 show that the test labels all the individuals as non-diseased and diseased, respectively. In addition, the point ( )
shows the perfect classification. Therefore, it is desirable that the ROC curve of a test to be closed as much as possible to the point ( );
Zhou et al. [21] .
In comparison between two diagnostic tests or markers, if the ROC curve of one has no points below another, then it weakly dominates the latter. If no points are below and at least one point is strictly above, then it dominates the An Optimal Combination of Several Binary Markers … 371 latter. The line x y = describes a diagnostic test that is no better than chance and consequently every desired test should dominate this line; see Barreno et al. [2] . As a result, among several diagnostic tests/markers, a test/marker is the best if it dominates the others at least in the weak sense. A number of indices have been introduced to summarize the information contained in the ROC curve. These indices provide a tool for comparing and evaluating diagnostic tests/markers. The most popular index is the area under the ROC curve (AUC) which represents the probability that a randomly chosen diseased individual has higher probability of being diseased than a randomly chosen non-diseased subject. For comparing two diagnostic tests/markers, the difference between AUCs is often used. Indeed, the larger area corresponds to the "better" test. For the diagnostic tests which are measured on "continuous" scales, Martin et al. [14] showed that the ROC curve based on the likelihood ratio (LR) statistic is uniformly above the ROC curve for all other scalar functions of the markers, and thus maximizes the AUC. For more details on ROC analysis, among others, see Pepe [15] , Fawcett [7] and Gonen [9] .
There are several diagnostic tests/markers for diagnosing a disease in practice. Indeed, a single marker does not have adequate sensitivity or specificity for diagnosis of most diseases. Therefore, a method for combining information from multiple diagnostic markers is needed. Certainly, a combined marker may provide a better tool for diagnosis applications than any single marker. For instance, cancers are heterogeneous with respect to the genes they over expressed. Therefore, cancers not expressing one tumor marker may express one or more others; see Martin et al. [14] and Bast [3] . Combining multiple diagnostic cancer tests to classify individuals into two diseased and non-diseased groups is the most interested problem in statistics and medicine. For multiple "continuous" diagnostic tests/markers, there are several approaches for combining the tests including normal linear discriminate analysis (Su and Liu [18] ), regression trees (Woolas et al. [19] ), artificial neural networks (Zhang et al. [20] ) and binary regression methods (Martin et al. [14] ).
Saeedeh Pourahmad et al. 372
Most of the discussed methods for combining multiple makers are based on "continuous" diagnostic tests while the simplest and often more clinically relevant form of a diagnostic test is a binary test (a marker with two categories: positive or negative). This test provides the presence or absence of abnormality; see Pfeiffer and Efstathia [17] . For example, there are several binary diagnostic markers for classical Hodgkin lymphoma (CHL). It is clear that combining these markers may provide a better tool for diagnosis. As Bandos et al. [1] noted the background of inferences about ROC curves based on binary data came back to almost half a century ago. However, methods for combining several binary diagnostic tests are seldom investigated in statistical and medical literature.
In this paper, we utilize an approach to combine the results of several binary markers. In order to derive an optimal combined diagnostic test without any assumptions for the distribution of the markers, NeymanPearson lemma (or equivalently LR method) is applied which is well-known to statisticians for medical diagnostic tests. The proposed combined diagnostic test is optimal in the sense that its ROC curve is maximized at every point and therefore its AUC is maximized. For calculating the AUC of a binary diagnostic test, see, e.g., Bandos et al. [1] , Cantor and Kattan [4] , and Desbiens [5] . Actually, the utilized approach was proposed by Barreno et al. [2] in another context (Computer Science and Machine Learning). They provided the ROC curve which is obtained by the LR method. They called this ROC curve the LR-ROC curve. We used the idea of LR-ROC curve to combine several binary diagnostic markers. We also illustrate the proposed method by obtaining an optimal combination of several immunohistochemical markers for the diagnosis of classical Hodgkin lymphoma (CHL). Although we used this approach for CHL, the utilized approach is applicable for other diseases that are diagnosed by binary markers. The main purpose in this clinical example is to obtain optimal decision rules to help distinguishing between CHL and non-Hodgkin lymphomas (NHL) along with the morphology.
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The Proposed Method
In this section, we discuss the ROC curve for a binary diagnostic marker and then we describe how to combine several binary diagnostic markers to obtain an optimal diagnostic test.
The ROC curve for a binary diagnostic marker
Sensitivity and specificity are two well-known quantities to evaluate the ability of a binary diagnostic test. Sensitivity (TPR) is the probability to put a person in diseased group (positive category) while he/she is certainly diseased and specificity (1-FPR) is the probability to place a person in nondiseased group (negative category) when he/she is certainly non-diseased; see Fawcett [7] . The high values of these two quantities are desirable for a test. To evaluate the performance of a binary test, different indices that are combinations of TPR and FPR have been proposed such as Youden, accuracy, odds ratio, expected utility and LR. However, the results of these indices may not be in agreement due to the difference in their definitions. For instance, a test with high LR value may have low Youden index or vice versa; see Bandos et al. [1] .
In order to visualize the result of a binary test, following Barreno et al. [2] , the values of TPR and FPR for that test are calculated and the point (TPR, FPR) in ROC curve space is connected to the points ( ) with straight broken lines; see Figure 1 . If an ordinal underlying variable is assumed for a binary test, then the original concave and non-decreasing ROC curve of binary test is not placed under these lines. These two broken lines in Figure 1 represent the lower band of all concave and non-decreasing ROC curves for this test (Bandos et al. [1] ). Accordingly, the area under these two broken lines can be treated as the minimum original AUC for the binary test which is equal to ( ) .
In this paper, this area is computed and utilized as the comparison index.
Furthermore, since the closeness of the ROC curve to the point ( )
indicates the high ability of the test to detect the diseased and non-diseased individuals, the Euclidian distance of ROC curve's points to this point is also used as a selection criterion for the best test. The ROC curve for a binary diagnostic test/marker.
Combining binary markers
We use Neyman-Pearson lemma to combine the binary markers and obtain an optimal marker combination. Accordingly, some points will be obtained in the ROC curve space and the combined ROC curve is achieved by connecting these points together. Note that the Neyman-Pearson lemma results most powerful test procedure in the classical hypothesis testing issue. However, the most powerful test procedure is equivalent to a diagnostic test that its ROC curve has the maximum value of TPR at a pre-specified bound on FPR. Therefore, using the Neyman-Pearson lemma to combine the binary markers leads to an optimal ROC curve. 
These values can be regarded as the probability distribution of Y under 0 = C or 1 in the underlying population.
3. Then the LR values, ( ),
and they are sorted from small to large.
be the error rate in decision. For a fixed value of α, the values of τ and γ are chosen such that
).
For a given value α (a bound on the FPR), an individual is classified as diseased, non-diseased, or diseased with probability γ if the value of ( ) y l for that individual is larger than, less than, or equal to τ, respectively. Therefore, the proposed optimal combined diagnostic test can be used to classify a new referred individual.
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6. To obtain the optimal combined ROC curve, for different values of α, the value of T P (i.e., TPR) is computed as
Note that the value of F P (i.e., FPR) is α. By connecting the points ( ) T F P P , in the ROC space, the optimal composite ROC curve is obtained.
The AUC index and the closest points ( ) 
Clinical Example
In this part, we illustrate the proposed method with a clinical example which is about several immunohistochemical markers for the diagnosis of CHL.
Data
A total of 470 individuals participated in the present study. They were referred to Namazi Hospital and Shahid Faghihi Hospital affiliated to Shiraz University of Medical Sciences (in Shiraz, Southern Iran) for diagnosis and classification of lymphoproliferative disorder during 2008 to 2013. According to their experimental laboratory data and clinical expert opinion, the individuals divided into two classical Hodgkin and non-Hodgkin lymphoma groups. Therefore, the definitive diagnosis for these individuals has been occurred (study sample). In this study, CHL was treated as diseased and NHL as non-diseased groups. In order to derive the optimal composite diagnostic panel of markers for CHL, six important binary markers were chosen.
CHL and related diagnostic markers
Hodgkin lymphoma accounting for nearly 15 In the present study, six important markers in diagnosis including CD15, CD20, CD30, CD3, Pax-5 and LCA were utilized for making different combinations.
Results
Based on participants' findings, the mean age was 44.5 (s.d. 20.8) and the number of men was significantly higher (62.1%). Separately by groups, the mean ages were 32.2 (s.d. 15.7) and 50.2 (s.d. 20.4) and percent of men were 60.8% and 62.7% for CHL and NHL groups, respectively. As mentioned earlier, six experimental markers were used for diagnosis in present research. All of them were binary markers (positive/negative). Table Table 1 There are 57 different ways to choose the subsets of two or more markers for combination. However, it is not clinically reasonable to apply some of them for diagnosis. Therefore, eleven subsets of these markers were chosen based on the clinical expert suggestion. The six steps described in the previous section were conducted to combine these eleven subsets of markers. It is seen from Table 2 that the use of all six markers (subset 11) and subset 9 lead to most accurate diagnosis (the maximum value of AUC and the minimum Euclidean distance to ( )
among eleven subsets). However, the subsets 7 and 8 (considered four-combination subsets) and the subsets 2, 4 and 6 (among considered three-combination subsets) are in the second and third ranks in terms of the value of AUC, respectively. Figure 2 displays the ROC curve for each six markers along with the optimal combined ROC curve based on the six markers. The utilized method for combination of these markers leads to an optimal ROC curve not only in comparison with the single marker but also with any other Boolean combination; see Barreno et al. [2] . To derive the combined decision rules for each subset, the value of α (the probability of Hodgkin lymphoma diagnosis incorrectly) was assumed to be 0.05. Then the values of τ and γ were calculated for each subset and the optimal decision rules were obtained by equation (4) . Table 3 represents these optimal combined rules for each subset. It is worthwhile mentioning that these rules are most powerful decision rules since they are obtained based on the Neyman-Pearson lemma. (1) CD20, CD30, LCA 1 ( )
The interpretation of optimal combined decision rules at error rate Table 4 occurs. Table 5 happens. Table 6 summarizes the relevant sequences. As a result, an individual can be diagnosed as diseased at error rate 05 . 0 = α if at least one of the sequences in Table 6 happens. 
In addition, an individual can be considered as CHL or NHL if for him/her, the value of ( ) y l is greater or less than 0.0518, respectively. Table 7 summarizes the relevant sequences.
Accordingly, an individual can be diagnosed as diseased at error rate
if at least one of the sequences in Table 7 happens. Note that according to the clinical texts, there are several decision rules for diagnosing CHL based on markers CD15, CD20, CD3, CD30, Pax-5 and LCA; see Joachim and Medeiros [12] . Some of these rules are shown in Table 8 . 
Discussion and Conclusion
In the present study, plotting the ROC curve for binary diagnostic markers was investigated. In addition, a method for combining several binary markers to obtain an optimal decision rule was discussed. As an example, optimal decision rules for diagnosing and differentiating CHL from NHL were obtained by combining six important binary markers. The rules were optimal in the sense that the ROC curve of optimal decision was maximized at every point. The optimal combination of markers provides optimal rules to make decision on an individual status of being diseased (CHL) or nondiseased (NHL) at any specified error rate decision (0.05 in the present study). Most of the previous researches on combining the results of the diagnostic tests worked on continuous variables with different methods or objective functions, see for instance, Barreno et al. [2] . For combining several binary diagnostic tests, a similar approach to the LR-ROC curve method is based on AND (i.e., all markers are positive) and OR (i.e., at least one marker is positive) Boolean functions; see Khreich et al. [13] and Etzioni et al. [6] . However, Barreno et al. [2] showed theoretically that the LR-ROC curve of several binary diagnostic tests weakly dominates the ROC curve of any possible combination of Boolean functions. Therefore, the method of combining tests by Boolean AND and OR functions did not apply in this study.
The proposed optimal rules did not assume any assumption for the distribution of markers while some researches assumed that the distribution of markers is conditionally independent; see, e.g., Haker et al. [10] . Furthermore, if conditionally independent distributions are assumed for the outputs of n binary markers, then the points in ROC space for the AND and OR rules are strictly above the convex hull of the ROC curves of n markers and these Boolean rules belong to the proposed optimal ROC curve; see Barreno et al. [2] .
To the best of our knowledge, this study may be the first practical research which applies this combination method on a real clinical data set. Therefore, there are no similar studies to compare their results with ours.
Moreover, it may be the first theoretical research on discrimination between CHL and NHL by statistical methods. At the end, it should be noted that since the proposed optimal decision rules in the present study (Table 3) are derived from the likelihood ratio values and these values are calculated based on the observed frequencies of CHL and NHL individuals referred to hospitals affiliated with Shiraz University of Medical Sciences, Southern Iran (equations (2) and (3)), they are local diagnostic rules and updating them for different geographical area is recommended to other researches for comparison. Furthermore, although Tables 4 to 7 represent some diagnostic sequences for CHL disease based on the optimal rules summarized in Table 3 at , 05 . 0 = α they should be applied along with morphology to make the definite diagnosis.
